ADYX - Adynxx, Inc.

0   0%

Share volume: 0
Last Updated:
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: 0.00%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
12%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 30%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
N/A
P/E Ratio 
N/A
DAY RANGE
N/A - N/A
EPS 
N/A
52 WEEK RANGE
N/A - N/A
52 WEEK CHANGE
N/A
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: David Ian Johnson
Region: US
Website: www.alliqua.com
Employees: 6
IPO year: 2019
Issue type:
Market: OTCM
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Adynxx, Inc. focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. The company was founded in 2007 and is headquartered in San Francisco, California.

Recent news
No news available